What Olympia Pharmacy offers for weight management now
Olympia Pharmacy's current compounded GLP-1 option is liraglutide, offered through both 503A patient-specific prescription and 503B office-use pathways. Liraglutide (sold as Saxenda for weight management and Victoza for diabetes) works through the same GLP-1 receptor mechanism as semaglutide, but requires daily injections rather than weekly, and the maximum dose for weight management is 3 mg daily. Patients and clinics switching from weekly semaglutide should understand that daily dosing means faster vial consumption and a different patient adherence profile. Olympia has also continued to invest in its hormone therapy, peptide, longevity injectable, and IV nutrition formularies — which are unaffected by the GLP-1 regulatory changes.
Pricing for compounded liraglutide on Olympia Pharmacy follows the same quote-driven model as the rest of its catalog: no published per-vial rates, custom clinical-liaison quotes, volume-negotiated terms. Because liraglutide requires daily dosing, per-dose cost and monthly supply economics differ from what clinics calculated for weekly semaglutide. Ask for written per-vial and per-dose cost across the titration ladder you prescribe — 0.6, 1.2, 1.8, 2.4, and 3.0 mg doses — so your patient pricing and margin math are accurate at each stage.